Evidence map›Paper›PMID 35528068›Full record

ArticleRSC advances2019

Untargeted metabolomics using liquid chromatography coupled with mass spectrometry for rapid discovery of metabolite biomarkers to reveal therapeutic effects of

Fu-Jiang Zhao, Zhao-Bo Zhang, Ning Ma, Xiao Teng, Zhen-Cheng Cai, Ming-Xi Liu

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fu-Jiang ZhaoDepartment of Orthopaedics, Taizhou Central Hospital, Taizhou University Hospital Taizhou 318000 China 1594864340@qq.com +86-18767620975 +86-18767620975.
Zhao-Bo ZhangDepartment of Orthopaedics, Taizhou Central Hospital, Taizhou University Hospital Taizhou 318000 China 1594864340@qq.com +86-18767620975 +86-18767620975.
Ning MaDepartment of Orthopaedics, Taizhou Central Hospital, Taizhou University Hospital Taizhou 318000 China 1594864340@qq.com +86-18767620975 +86-18767620975.ORCID https://orcid.org/0000-0002-6334-667X
Xiao TengDepartment of Orthopaedics, Taizhou Central Hospital, Taizhou University Hospital Taizhou 318000 China 1594864340@qq.com +86-18767620975 +86-18767620975.
Zhen-Cheng CaiDepartment of Orthopaedics, Taizhou Central Hospital, Taizhou University Hospital Taizhou 318000 China 1594864340@qq.com +86-18767620975 +86-18767620975.
Ming-Xi LiuDepartment of Orthopaedics, Taizhou Central Hospital, Taizhou University Hospital Taizhou 318000 China 1594864340@qq.com +86-18767620975 +86-18767620975.
Taizhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid chromatography coupled with mass spectrometry has been used as metabolomics profiling tool to discover and identify the metabolites in metabolic diseases. Osteoporosis (OP) syndrome is a chronic metabolic disease characterized by bone mass reduction and changes in bone microstructure.

Identifiers

PMID35528068
PMCPMC9074708
OpenAlexW2986957198

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.